Kalbe Farma Tbk PT
IDX:KLBF

Watchlist Manager
Kalbe Farma Tbk PT Logo
Kalbe Farma Tbk PT
IDX:KLBF
Watchlist
Price: 1 485 IDR 1.37% Market Closed
Market Cap: 68.7T IDR
Have any thoughts about
Kalbe Farma Tbk PT?
Write Note

Relative Value

The Relative Value of one KLBF stock under the Base Case scenario is 1 921.24 IDR. Compared to the current market price of 1 485 IDR, Kalbe Farma Tbk PT is Undervalued by 23%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

KLBF Relative Value
Base Case
1 921.24 IDR
Undervaluation 23%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
85
vs Industry
46
Median 3Y
2.7
Median 5Y
2.8
Industry
2.5
Forward
2.3
vs History
57
vs Industry
19
Median 3Y
24.7
Median 5Y
24.6
Industry
21.9
Forward
21
vs History
95
vs Industry
23
Median 3Y
27.3
Median 5Y
23.6
Industry
16.5
vs History
69
vs Industry
16
Median 3Y
55.1
Median 5Y
42.2
Industry
23.6
vs History
82
vs Industry
24
Median 3Y
3.8
Median 5Y
3.8
Industry
2.1
vs History
82
vs Industry
47
Median 3Y
2.5
Median 5Y
2.6
Industry
2.6
Forward
2.2
vs History
60
vs Industry
35
Median 3Y
6.3
Median 5Y
6.2
Industry
5.2
vs History
47
vs Industry
20
Median 3Y
18.5
Median 5Y
17.7
Industry
13.3
Forward
13.4
vs History
47
vs Industry
23
Median 3Y
18.5
Median 5Y
17.7
Industry
16.6
Forward
15.3
vs History
87
vs Industry
24
Median 3Y
25.1
Median 5Y
22.5
Industry
15.6
vs History
88
vs Industry
16
Median 3Y
38.7
Median 5Y
38.7
Industry
19.1
vs History
84
vs Industry
27
Median 3Y
3.7
Median 5Y
3.7
Industry
1.9

Multiples Across Competitors

KLBF Competitors Multiples
Kalbe Farma Tbk PT Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
ID
Kalbe Farma Tbk PT
IDX:KLBF
68.7T IDR 2.2 22.6 16.7 16.7
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
710.5B USD 17.4 84.9 45.7 51
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35 24.3 27.8
US
Johnson & Johnson
NYSE:JNJ
373.5B USD 4.3 25.4 12.3 16
US
Merck & Co Inc
NYSE:MRK
251.1B USD 4 20.7 10.5 12.5
CH
Roche Holding AG
SIX:ROG
202.7B CHF 3.5 17.6 9.9 11.8
CH
Novartis AG
SIX:NOVN
183.3B CHF 4.1 11.6 10.1 14
UK
AstraZeneca PLC
LSE:AZN
162.4B GBP 4.1 31.6 169.4 253.9
IE
Endo International PLC
LSE:0Y5F
146B USD 63 -49.9 234.4 587.7
P/E Multiple
Earnings Growth
ID
Kalbe Farma Tbk PT
IDX:KLBF
Average P/E: 31.2
22.6
42%
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
84.9
451%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
35
86%
US
Johnson & Johnson
NYSE:JNJ
25.4
-22%
US
Merck & Co Inc
NYSE:MRK
20.7
7 321%
CH
Roche Holding AG
SIX:ROG
17.6
32%
CH
Novartis AG
SIX:NOVN
11.6
21%
UK
AstraZeneca PLC
LSE:AZN
31.6
177%
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -49.9 N/A

See Also

Discover More
Back to Top